Perspective Therapeutics CATX
NYSE CATX
$2.73 +0.01 (+0.55%)
As of: Oct 2, 2026 · 12:44 PM EDT

Perspective Therapeutics (CATX) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Perspective Therapeutics' Depreciation & Amortization (CF) was $1.14 million in Q2 2026, up 55.7% from $733,000 a year earlier and up 1.3% from the prior quarter.

Analysis

Perspective Therapeutics (CATX) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Perspective Therapeutics' Depreciation & Amortization (CF) was $4.05 million through Jun 30, 2026, up 42.6% year-over-year; for FY2025, it was $3.25 million, up 41.0% from FY2024.

  • Depreciation & Amortization (CF) has now increased for three consecutive years, with a five-year compound annual growth rate of 85.8% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $2.31 million in FY2024 (+133.9%), $986,000 in FY2023 (+269.3%), $267,000 in FY2022 and $149,000 in FY2021 (+1.4%).
  • The Q2 2026 figure marks the highest quarterly Depreciation & Amortization (CF) in data going back to Q4 2022.
  • Compared with a year earlier, Depreciation & Amortization (CF) has increased for ten straight quarters, with growth averaging 74.3% over the last eight quarters.
  • The year-over-year growth in Depreciation & Amortization (CF) has ranged between 15.8% (Q3 2025) and 158.3% (Q3 2024) over the last five years.
  • Per Business Quant data, CATX's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $1.13 million (Q1 2026), $1.01 million (Q4 2025) and $775,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Perspective Therapeutics 312.60 Mn 312.60 Mn - 1.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.14 Mn
Mar 31, 2026 1.13 Mn
Dec 31, 2025 1.01 Mn
Sep 30, 2025 775,000.00
Jun 30, 2025 733,000.00
Mar 31, 2025 732,000.00
Dec 31, 2024 709,000.00
Sep 30, 2024 669,000.00
Jun 30, 2024 572,000.00
Mar 31, 2024 356,000.00
Dec 31, 2023 302,000.00
Sep 30, 2023 259,000.00
Jun 30, 2023 255,000.00
Mar 31, 2023 190,000.00
Dec 31, 2022 -45,000.00
Sep 30, 2022 67,000.00
Jun 30, 2022 75,000.00
Mar 31, 2022 74,000.00
Dec 31, 2021 60,000.00
Sep 30, 2021 59,000.00
API Access

Perspective Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CATX&period=max&api_key=YOUR_API_KEY